Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers

被引：0
作者：
J Fujimoto
H Sakaguchi
I Aoki
S Khatun
T Tamaya
机构：
[1] Gifu University School of Medicine,Department of Obstetrics and Gynecology
来源：
British Journal of Cancer | 2001年 / 85卷
关键词：
VEGF; metastatic lesion; patient prognosis; ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumour angiogenesis, which is essential for the growth, invasion and metastasis of solid tumours. Significantly increased VEGF level from the primary tumour to the metastatic lesion of ovarian cancers was found in 8 of 30 cases. The 24-month survival rate of the patients with significantly increased VEGF level was extremely poor (0/8 = 0%) in comparison with that of patients with no change in the level (15/22 = 68%) from the primary tumour to the metastatic lesion. This indicates that VEGF may contribute to the advancement of metastatic lesions, and that VEGF level in metastatic lesions may be a prognostic indicator. © 2001 Cancer Research Campaign
引用
收藏
页码：313 / 316
页数：3
相关论文
共 129 条
[1]  
Abu-Jawdeh GM(1996)Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in ovarian borderline and malignant neoplasms Lab Invest 74 1105-1115
[2]  
Faix JD(1993)Expression of vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms J Clin Invest 91 153-159
[3]  
Niloff J(1995)Expression of vascular endothelial growth factor and its receptor flt and KDR in ovarian carcinoma JNCI 87 506-516
[4]  
Tognazzi K(1996)Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiogenic therapy from intravital videomicroscopy Cancer Res 56 4032-4039
[5]  
Manseau E(1976)A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 315-323
[6]  
Dvorak HF(1984)Vascular as a target for tumor therapy Prog Appl Microcirc 4 28-38
[7]  
Brown LF(1993)Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival Gynecol Oncol 51 224-229
[8]  
Berkman RA(1985)Tumor angiogenesis Adv Cancer Res 43 175-203
[9]  
Merrill MJ(1998)Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers Cancer Lett 134 15-22
[10]  
Reinhold WC(1998)Biological implication of the expression of vascular endothelial growth factor (VEGF) subtypes in ovarian cancers Cancer 83 2527-2533
12345678910